Medtronic plc.

Open: 75.14 Close: 74.76 Change: -0.38

Our AI found unexpected things about Medtronic plc..

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, company, healthcare, Medtronics, FDA, hypertension, approval, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Shares of Medtronic PLC MDT slumped 0.16% to $74.76 Friday, on what proved to be an all-around positive trading session for the stock market. Medtronics is a medical technology company.

Today's News

Shares of Medtronic PLC MDT slumped 0.16% to $74.76 Friday, on what proved to be an all-around positive trading session for the stock market. Medtronics is a medical technology company. Medtronic (NYSE: MDT) operates as a healthcare solutions company. US FDA approves Medtronics blood pressure treatment device for use. Medtronic is the 140th most valuable company by market cap according to our data. 1.2 billion people worldwide are estimated to have hypertension. Accounting News Roundup: Medtronic gets in on inversion; Deloittes New Seattle OMP; Grant Thorntons Dr. Poof Problem. Medtronic announces fda approval of minimally invasive device to treat hypertension. DTM SCS program was able to significantly lower pain in patients suffering from a number of degenerative disorders. A majority of Americans are optimistic that AI will improve healthcare in 2024, according to a new survey from Medtronic and Morning Consult. Some of the highest levels of optimism for AI in healthcare are around diagnoses and improving healthcare access. Medtronic PLC share price is 74.76 USD today. The Medtronics Symplicity Spyral renal denervation system granted US FDA approval for hypertension treatment 19th November 2023. The company has announced approval from the USA Food and Drug Administration (FDA) for the Symplicic Spyral Renal Denervation system.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, company, healthcare, Medtronics, FDA, hypertension, approval, and the most common words in the summary are: medtronic, stock, plc, mdt, subscribe, market, company, . One of the sentences in the summary was: Shares of Medtronic PLC MDT slumped 0.16% to $74.76 Friday, on what proved to be an all-around positive trading session for the stock market. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #plc #mdt #subscribe #market #company.